Cabaletta Bio is trading at $1.52, with a -6.48% change in pre-market; broader market pressure is a plausible factor.
- No clear company-specific explanation surfaced in the available news search; its news page’s latest listed update was October 5.
- Reuters reported hotter-than-expected U.S. inflation pressured stocks and technology shares, while declines continued in Asian markets on October 15.
- The Nasdaq Composite was down 1.39% pre-market, pointing to global-market pressure rather than a confirmed company-specific catalyst.